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Rapid, low-cost, species-specific diagnosis, based upon DNA testing,
is becoming important in the treatment of patients with infectious
diseases. Here, we demonstrate an innovation that uses origami to
enable multiplexed, sensitive assays that rival polymerase chain
reactions (PCR) laboratory assays and provide high-quality, fast
precision diagnostics for malaria. The paper-based microfluidic tech-
nology proposed here combines vertical flow sample-processing
steps, including paper folding for whole-blood sample prepara-
tion, with an isothermal amplification and a lateral flow detection,
incorporating a simple visualization system. Studies were performed
in village schools in Uganda with individual diagnoses being com-
pleted in <50 min (faster than the standard laboratory-based PCR).
The tests, which enabled the diagnosis of malaria species in patients
from a finger prick of whole blood, were both highly sensitive and
specific, detecting malaria in 98% of infected individuals in a double-
blind first-in-human study. Our method was more sensitive than
other field-based, benchmark techniques, including optical micros-
copy and industry standard rapid immunodiagnostic tests, both per-
formed by experienced local healthcare teams (which detected
malaria in 86% and 83% of cases, respectively). All assays were in-
dependently validated using a real-time double-blinded reference PCR
assay. We not only demonstrate that advanced, low-cost DNA-based
sensors can be implemented in underserved communities at the point
of need but also highlight the challenges associated with developing
and implementing new diagnostic technologies in the field, without
access to laboratories or infrastructure.
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Malaria is a leading cause of morbidity and mortalityworldwide. There are >219 million cases in 90 countries,
with more than 435,000 deaths in 2017 (1). Despite efforts in re-
cent years surrounding preventive interventions, including bed
netting, insecticide spraying, and mass prophylactic drug admin-
istration, progress has stalled. The 2018 World Health Organiza-
tion (WHO) malaria report (1) highlights that, after almost two
decades of decline, malaria cases have significantly risen in
13 countries, stating that no significant progress has been made in
reducing global malaria between 2015 and 2017 (before then, the
number of people contracting the disease had been falling). This
has prompted concern that more is needed to combat the epi-
demic, and the report highlights the need for species-specific di-
agnostics before treatment. Health workers are increasingly calling
for low-cost, rapid diagnostic devices that require no refrigeration,
laboratory equipment, or special training, but that can detect
parasites even when they are not abundant.
It has also recently become clear that existing standard field
tests for many infections, including malaria, are not reliable, and
new strategies are now needed to deliver effective diagnostics to
reduce the burden of disease. As part of such a strategy, effec-
tive, sensitive and accurate, species-specific detection is needed
to direct therapy in a more informed manner (2). The impor-
tance of identifying disease reservoirs in asymptomatic patients is
also particularly important in disease elimination programs and
provides a challenge that current techniques cannot meet.
Rural, remote, underserved communities, where many infectious
diseases are most prevalent, can bear the largest social, healthcare,
and economic burdens. Treatments are often prescribed based on
presumptive diagnosis, due to the inability to perform reliable,
precise tests on site (3). Light microscopy has long been the “go-to”
standard technique used to diagnose malaria in such areas, and
requires only a microscope and a trained technician to achieve
detection sensitivities of 100 parasites per microliter of blood (4).
However, this diagnostic technique cannot detect asymptomatic
patients, who have very low, persistent parasite loads in their blood.
This is a key challenge, for the identification of these patients is
required to treat all infectious reservoirs, thereby working toward
important WHO targets concerning disease elimination (5).
When microscopy-based diagnosis is performed by highly
trained technicians, it can, however, identify the parasitic species
concerned, which is essential for targeting treatment effectively
(6). Similarly, point-of-care immunoassays, also known under the
generic term of rapid diagnostic tests (RDTs), are based upon a
hand-held lateral flow technology and are also widely used in
low-resource areas. They are able to detect the presence of
species-specific antigens derived from the malarial parasites,
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from a finger prick of blood in ∼15 min. The methods use no
instrumentation and no electrical power, as the blood sample
flows through the paper via capillary forces (7). However, the
performance of such assays has been limited by their generation
of false-positive results, which occur when nonspecific biomole-
cules present in the blood, such as the rheumatoid factor, for
example, react with the test antigens (8). Technical issues linked
to capillary flow and to reagent stability in challenging environ-
mental conditions, including high humidity and temperature (9),
have also affected the reliability of RDT immunodiagnostics. Test
sensitivities are often only 70 to 75% in the field (10), despite
being much higher in well-controlled laboratory conditions (11).
Their performance is significantly less than globally accepted
targets set by key stakeholders, such as the WHO and Foundation
for Innovative Diagnostics (FIND), who target 97% sensitivity as a
minimal requirement (12). To have a significant impact in di-
agnosing malaria, in future, RDTs will need to demonstrate im-
proved sensitivity and accuracy, as well as adequate performance
under adverse field conditions (13).
Nucleic acid amplification-based tests (NAATs) provide a
promising approach for DNA-based malaria diagnostics. These
tests both amplify and detect the genomic material of the para-
site directly from a patient sample, providing a sensitive, species-
specific test that will also identify whether an infection is current
rather than historical (6, 14). In addition, the signal used for
detection does not depend on the patients’ immune responses,
and the technique can be both quantitative and more accurate
than immuno-RDTs (15). Such tests are also now seen as being
critical to elimination programs, not only for malaria but for
other infectious diseases, given that they can detect low levels of
asymptomatic infections, which may act as reservoirs for future
disease emergence.
In many reference laboratories, PCR-based amplification as-
says remain the gold-standard NAAT (16), although the re-
quirement for trained staff and external power has limited their
application in areas with reduced resources. Loop-mediated
isothermal amplification (LAMP) of DNA (17) and other simi-
lar isothermal amplification methods have recently emerged as
easy-to-use alternatives to PCR (14), owing to greatly simplified
hardware requirements. For example, no temperature cycling is
required by these techniques, and their amplification products
can be detected visually (18). Where power supplies and labo-
ratory infrastructure can be established (such as during an epi-
demic), NAATs can often be implemented (19, 20). However,
these methods have limited multiplexing ability, due to the complex
sample preparation steps required (21).
Recently, lateral flow techniques have been combined with
PCR for end point detection (22) by using conventional labo-
ratory equipment. The testing of clinical samples for nucleic
acids has also been performed for infectious disease diagnosis in
resource-limited environments (21, 23), for example, to detect
Ebola virus from extracted RNA. For the first time, this has
brought NAAT-based diagnostics closer to patients in rural
communities, with samples being stored and assayed in a field
laboratory facility (24).
We recently reported a diagnostic platform that uses paper
folding (origami) to integrate the different blood sample prep-
aration steps that are required for LAMP onto a paper micro-
fluidic device (25). We used this technique in a hospital setting to
test clinical samples and demonstrated the identification of specific
malarial species in a multiplexed, sample-to-answer, paper-based
microfluidic device. This platform was subsequently used success-
fully in a field-based laboratory setting in India to detect sexually
transmitted diseases in cattle (26). However, in both cases, the
detection step was based on a fluorescent readout, which presented
challenges, both in its performance and its ease of use. For example,
the readout was difficult to assess quantitatively in varying levels of
ambient light. This optical detection method was particularly
ambiguous at low levels of infections, when the signal-to-background
was small.
To overcome this uncertainty in visual signal measurement, we
now present a format for a paper-based microfluidic device that
uniquely combines our previously published vertical sample-
processing steps of the origami device (25) with a microfluidic
lateral flow LAMP amplification and detection platform. This
facilitates data analysis by healthcare workers, providing an easy-
to-use display of the results. Importantly, the integration of this
lateral flow readout avoids the inherent ambiguity of fluores-
cence outputs, supporting the deployment of these diagnostic
devices in rural communities (where there is a requirement that
results can be readily and accurately interpreted; Fig. 1).
The performance of the device was evaluated in humans in
primary schools in St. Kizito and Mayuge Districts, Uganda, on
67 patients. Its effectiveness was benchmarked against two stan-
dard field-based techniques, RDT and light microscopy run at
the same time, as well as against a laboratory-based, real-time
PCR assay, carried out retrospectively.
The sample-processing steps performed by this paper-based
microfluidic device included DNA extraction, LAMP isothermal
amplification, and lateral flow antibody-based detection of DNA
amplicons. The nucleic acid amplification step was demonstrated
in the laboratory to characterize the device performance, including
20 negative patient samples (SI Appendix, Fig. S2) and, impor-
tantly, 67 patients in the field, with amplification being performed
either on a simple hot plate (n = 59) or in a water bath, main-
tained at a constant temperature on a cooking stove (n = 8).
The test was designed as a multiplexed assay to identify
Plasmodium falciparum, the endemic malaria-causing parasitic
species in the region of study, as well as Plasmodium pan (to detect
all other parasitic species that cause malaria, which might be present
for various reasons, such as human migration). The innovations that
we describe demonstrate the potential for such tests, either in the
precise diagnosis of disease enabling informed species-specific
therapy or, in the future, for global surveillance or screening. The
technique is now being evaluated by healthcare professionals from
the Uganda Vector Control Division, Ministry of Health, for use
in rural areas without access to centralized facilities.
Results
The paper-based vertical flow origami sample-processing unit
and the lateral flow assay, together with LAMP assays and gold-
standard (laboratory test) PCR assays, were all developed and
optimized for fieldwork, before departure, at the University of
Glasgow. The combination of using the origami sample processing
combined with a lateral flow assay represents a substantial im-
provement on our previous work with key advantages over previous
studies (25, 26), which had involved reading the results as a fluo-
rescence signal with a flashlight. These devices suffered from diffi-
culties in differentiating the nature and intensity of the fluorescence,
particularly in variable ambient light conditions found within rural
settings. The incorporation of a semiquantitative lateral flow assay
not only speeded up the measurements but also gave increased
confidence in the diagnosis.
Device Design and Fabrication. The paper origami device for DNA
extraction was fabricated using an inexpensive hot wax printing
method (Fig. 1A), with adaptations to published methods (25,
27). The folding-based, sample-processing steps are illustrated in
Figs. 1 and 2 (and are also detailed in Movie S1). The lateral flow
component of the assay was designed in the University of
Glasgow and was fabricated by Ustar (28).
A finger-prick blood sample was added to an RDT, to an
Eppendorf tube, to a “fast transient analysis” (FTA) card (for
retrospective analysis with PCR amplification assays), and to
glass slides for thick smears using Giemsa staining and optical
microscopy. The same blood was used immediately (before
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clotting, <2 min) for the microfluidic paper test. Ten microliters
of lysis buffer containing magnetic beads was added to 5 μL of
blood. After 5 min, a further aliquot of binding buffer was added,
and the DNA was captured on the beads, which were transferred
to the sample zone of the folded (origami) paper device (Figs. 1A
and 2B) as a 40-μL volume. All residues were then washed
off manually by dispensing a volume-independent aliquot of a
washing buffer onto the sample reception area; excess buffer and
residues were then drained away under capillary force by folding
the reception panel against a waste panel (Figs. 1A and 2B).
The bead-bound DNA was retained within the paper matrix,
which was then refolded against distributing channels (Fig. 2 C
and D) before elution buffer was added. Within the distribution
channel, the sample was split into three spots (as a multiplex),
which themselves then formed the independent LAMP chambers
(Fig. 1A, arrow 5). The sample-preparation processing requires
two manipulations, namely, the addition of washing and elution
buffers, a procedure easily performed by local healthcare workers.
In two of the chambers, DNA from Plasmodium pan and
P. falciparum were tested, while a separate chamber was used as
a control. The device was sealed with an acetate film to prevent
evaporation during the LAMP reaction at 63 °C for 45 min on a
hot plate, or in a water bath, heated on a cooking stove. If
Plasmodium DNA is present in the sample, a specific LAMP
reaction takes place in which amplicons are generated with both
biotin- and FITC-labeled primers, as a complex bearing two li-
gands (see SI Appendix, Fig. S1, which illustrates how the lateral
flow assay works and how its results are visualized).
Following the LAMP reaction, the test sample was then
transferred to the lateral flow strips (Fig. 1, location 2) using a
finger pump (29). The buffer moves the products of the LAMP
reaction laterally into the detection strips, and the assay proceeds
under capillary flow. In this way, the vertical sample-processing
steps of the origami device were integrated into a lateral flow-
mediated amplification and visual readout system. The detection
strips contain anti-FITC antibodies and immobilized streptavidin
in the test and control lines, respectively. This detection step takes
less than 1 min, and results were analyzed by eye (SI Appendix, Fig.
S1). When the complex, generated by the LAMP assay flows
through the lateral flow detection device, the species-specific li-
gands are captured to generate appropriate lines as a positive
result (SI Appendix, Fig. S1), with the nanoparticle-bound ligands
concentrated at the band.
If target DNA was not present in the sample and no amplifi-
cation had taken place, then only biotin−streptavidin conjuga-
tion occurs, which results as a single red line indicating a negative
result (SI Appendix, Fig. S1). In addition to a control line to show
that the lateral flow device worked, the diagnostic device also
included a positive control, consisting of a BRCA1 target am-
plified from artificial DNA targets as lane P, as a quality control
step (to rule out false negatives due to test failure in challenging
environmental conditions, such as high humidity and heat).
Laboratory-Based Characterization. As stated, we first verified the
sensitivity of the LAMP assay used in this device in a laboratory
setting in the United Kingdom, using a serial dilution of the
WHO International Standard for P. falciparum DNA (30). Fig.
3A shows the test results in the form of the test strips that were
generated, together with a quantification of the intensities of the
test line to validate the visual analysis (seeMaterials and Methods
for details). The analytical sensitivity of the Plasmodium pan
assay, which detects several Plasmodium species (including
P. falciparum, P. malariae, P. vivax, and P. ovale), was 105 IU/mL
after 45-min amplification. The P. falciparum assay detected this
species (alone) with a similar level of sensitivity as the Plasmo-
dium pan assay (Fig. 3C), in agreement with previously per-
formed laboratory-based assays, such as commercially available
LAMP kits (31).
We also evaluated the performance of rehydrated amplifica-
tion enzymes after storage at room temperature. Freeze-dried
Fig. 1. Paper-based microfluidic device that enables multiplex LAMP-based detection of malaria in blood. (A) An assembled paper−plastic lateral flow di-
agnostic device, used for amplification and detection. Attached to this device is a foldable paper strip that is used for DNA extraction and processing. (Fig. 2
shows, in detail, how this strip is folded). The unfolded paper strip consists of dark regions that are created by printing the paper with hydrophobic wax and
unpatterned regions that direct sample flow. The rightmost fold is the waste panel, the sample panel to its left shows where the sample is loaded, and the
distributing channel is where DNA is eluted for LAMP-based DNA testing. The final (leftmost) fold sits on top of the three LAMP testing chambers (denoted by
arrow 5). Pink shading on the lateral flow strip is due to the colored detection particles stored at this position (SI Appendix, Fig. S1). The scale bar relates to the
whole device. (B) A schematic of the plastic microfluidic device, highlighting its key features (1 to 5), namely: 1, buffer chambers, which produce fluid flow,
when pressed manually [as a finger pump (29)]; 2, lateral flow DNA detection strip; 3, acetate films to prevent sample evaporation and to enable safe
handling; 4, filter paper-based valves, which prevent the LAMP reaction from mixing with the buffer held in the buffer chambers (feature 1) during am-
plification, while also preventing it from flowing into the lateral flow strip prematurely [the contents of the LAMP reaction volume (feature 5) should only
reach the lateral flow strips after amplification, enabled by the flow of buffer from the buffer chambers (feature 1), following manual pumping of the
chambers]; and 5, filter paper for the LAMP reaction. The P channel provides a positive control for the LAMP reaction (to control for environmental conditions
and handling) using a synthetic DNA target. Red shading bands denote LAMP testing results (SI Appendix, Fig. S1).
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enzymes are commercially available in large batches, but, once
rehydrated, their stability becomes a key concern for the appli-
cation of NAATs in resource-limited areas, since there is limited
availability of cold storage facilities (32). We stored rehydrated
LAMP mixtures under three different conditions (−20 °C, 4 °C,
and at room temperature, i.e., ∼22 ± 2 °C) for 72 h, and mea-
sured their activity every 12 h, using a target concentration of
105 IU/mL, by real-time PCR and by using the DNA detection
strip used in the microfluidic device (Fig. 4 A and C). The results
demonstrated that rehydrated enzymes stored for 3 d at room
temperature showed no significant decrease in performance (Fig.
4B), supporting the use of these commercially available kits for
field-based trials, where cold storage is unavailable.
We repeated this experiment after the field study in Uganda,
using a sample of freeze-dried enzyme that was brought to
Uganda, stored there at local room temperature (ca. 20 °C to
35 °C) and brought back to the United Kingdom. SI Appendix,
Fig. S4 shows that the rehydrated LAMP reagent is stable after a
day of storage at temperatures up to 40 °C.
Clinical Study. The paper-based microfluidic device reported here
was assessed at rural primary schools in Mayuge and Apac
Districts in Uganda. Before clinical evaluation, an ethical as-
sessment was carried out with the Ministry of Health in Eastern
Uganda, including the treatment of children postdiagnosis.
Consent for the testing of children was obtained from the par-
ents, and a census was established to ensure that each child was
correctly associated with the parent who had given consent (see
Materials and Methods for details).
Blood samples from 67 children (aged from 6 y to 14 y old,
with equal sex ratios) were tested using the paper-based micro-
fluidic device. The results were compared with microscopy-based
diagnosis (performed by a trained and experienced technician
from the Vector Control Division of the Ministry of Health,
Uganda) and with a malaria RDT (seeMaterials and Methods for
details), performed in the field using the same blood sample.
To resolve discrepant results, finger-prick whole-blood sam-
ples were also spotted onto Whatman FTA classic cards, which
then underwent retrospective, double-blind testing (see Materials
and Methods for details) by real-time PCR using 18S rRNA gene
subunit-based Plasmodium sp. screening and P. falciparum
species-specific screening (6).
The results of the screening are summarized in Table 1 for
59 of the 67 samples (eight samples were used to evaluate a
frugal heating method, on a cooking stove, sourced locally, as
discussed further). Individual results, with ages and sexes of the
children, are available in SI Appendix (including individual Ct
values; see Dataset S1).
The regions where the tests were carried out are endemic for
malaria, and, out of the 67 samples tested, only three were
negative for the reference real-time PCR test. The extremely low
number of negative samples does not allow the specificity of the
device to be assessed. We note that one negative sample tested
as being positive by the paper-based microfluidic device. To
validate the capability of the device to detect negative samples in
a clinical setting, we tested 20 blood samples from healthy pa-
tients as a separate study (SI Appendix, Fig. S2), validated with
PCR. The paper-based tests correctly identified all samples (as
the experiments were performed in the laboratory, these results
are not included in our analysis of the performance of the de-
vices in the field; Tables 1 and 2).
Taking into account the tests for Plasmodium pan and P. fal-
ciparum, the paper-based microfluidic device had a sensitivity
of >98% and a coincidence rate of 97% (95% CI, 91.99 to
100%), compared with the test results generated by real-time
PCR (Table 1). Importantly, this sensitivity is above the mini-
mal performance target set out by WHO and FIND (12).
Our method was also more sensitive than the microscopy de-
tection method used (which detected infection in 86% of the
tested cases). The performance of both microscopy and RDTs
(82% sensitivity) was similar to those obtained by previous
studies and was not atypical of what might be expected (10, 27).
It is particularly interesting that many RDT tests perform less
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Fig. 3. LAMP assay validation. (A) The image shows the results of the LAMP-
based Plasmodium pan assay, which was used to detect several different
species of the Plasmodium parasite. Each lane represents a paper strip that
has been exposed to a sample containing a 10-fold serially diluted concen-
tration of Plasmodium standard (30), from 108 IU/mL to 104 IU/mL, together
with a negative control (ddH2O, Neg). The assay used to detect the different
Plasmodium species is shown in SI Appendix, Fig. S1. The C line represents
the control result, and the T line represents the test result. Note that the
intensity of the control lines for the negative results are higher than that for
the positive results, due to the fact that no beads are captured by the test
line. The test line is the first line encountered by the sample as it flows
through the lateral flow device (the direction of the flow is represented by
the arrow). (B) Intensity of the test line shown as a percentage of the control
line for each Plasmodium (target) concentration level. Data shown are the
average of three repeats, and error bars represent the SD. (C) Sensitivity
of P. falciparum LAMP with the 10-fold serially diluted target from 108 IU/mL
to 104 IU/mL together with a negative control (ddH2O as target). Examples
of real-time LAMP curves are available in SI Appendix, Fig. S3.
Fig. 2. Paper-folding steps for fluidic manipulation. Schematics of how the
paper strip in the microfluidic device is folded for each step. The arrows
indicate the direction of folding. (A) The layout of the multiplex paper de-
vice, which is linked to a plastic casing (Fig. 1) that contains the lateral flow
DNA detection strip. (B) The magnetic beads and the DNA in the sample are
mixed and added to the sample zone (*). Impurities are washed off using
washing buffer and drained onto the waste pad by folding the paper strip,
as shown in A (arrow). (C) The second (sample zone) and third panels are
then folded to come into contact with each other, forming a distributing
channel for DNA elution. (D). The distributing channel is then folded onto
the remaining square, which is then placed against the plastic device to
cover the three LAMP chambers (see arrow 5 in Fig. 1); these chambers each
contain a 3-mm filter paper frit that receives the DNA into the plastic device.
The reagents for the LAMP reaction are then added to the reaction cham-
bers. Movie S1 shows these sample-processing steps using mock samples.
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well in the field (10) than when carried out in more controlled
conditions; for example, the CareStart test, used in this study has
a sensitivity of 95.4% when performed in a hospital (11).
The paper-based microfluidic device reported here only failed
to detect one positive sample, which had a Ct value of 30 on the
real-time PCR benchmark assay, and therefore was not a low
parasitaemia titer.
We also note that the device can effectively enable the con-
centration and amplification of an analyte from a relatively large
volume of fluid in the finger-prick sample into small volume on
the lateral flow strip, a critical challenge for microfluidics. Con-
sequently, healthcare workers are able to differentiate P. falcipa-
rum infections from other species. Compared with species-specific
real-time PCR amplified assay, the sensitivity of the device for
diagnosing specific P. falciparum infections was 93%, which is
better than that of RDTs (82%) in our work, and again equivalent
to published results (33).
We also evaluated the capability of the device to be used with
minimal power requirements. For eight samples (see rows 66–73
in Dataset S1), we also performed the LAMP reaction on a local
cooking stove, using a water pan to heat the device. The temperature
of the water was controlled visually using a thermometer (SI Ap-
pendix, photo ESI-7), varying around 63 °C ± 4 °C. Using this
method, the paper origami device correctly detected four positive
samples (also positive by PCR) and two negative samples (also
negative by PCR). One of these positive samples was negative by both
RDT and microscopy. One additional positive sample was not de-
tected by the paper device, but this sample was also not detected by
any of the other field-based methods. One sample tested positive by
the paper device and negative for all other techniques. These ob-
servations would indicate that the paper device, when operated using
this frugal heating source, is more sensitive than RDT and micros-
copy but less sensitive than laboratory-based PCR.
Discussion
Species-specific multiplexed diagnosis for infectious diseases
using either immunodiagnosis or nucleic acid testing is typically
performed in centralized laboratories using blood samples pro-
cessed by trained personnel who require access to specialized
instrumentation (34). Although traditional multiplexed RDT
lateral flow devices for immunoanalysis exist, their performance
is less than needed in the field (10). In our study, we note that
the positive predictive values for the immuno-RDTs were very
good 46/(46+0 false positive), indicating that, if the diagnostic
test was positive, the patient is very likely to have malaria.
However, the negative predictive value for the RDT was 3/13,
indicating that, if the test gave a negative result, most often it was
incorrect.
In an attempt to overcome the problems associated with
immuno-RDTs, a new highly multiplexed microfluidic immuno-
diagnostic platform has recently been deployed in Kenya, al-
though the device requires laboratory-like conditions and further
optimization for its performance to be equivalent to reference
tests (35). Multiplexed PCR techniques for NAAT diagnosis of
infectious disease in resource-limited environments have also been
reported, using lateral flow for end point detection (22). Although
this has the potential to bring NAAT-based diagnostics closer to
patients in rural communities, the assay required conventional
equipment, and samples were stored in a field laboratory facility
(24).
LAMP isothermal amplification holds significant promise in
decreasing the complexity of the instrumentation required for
NAAT, although current applications of PCR and LAMP both
still remain restricted to well-equipped laboratories and thus are
not suitable for low-resource settings, unless field laboratories
are established locally (36). To date, the integration of PCR and/
or LAMP within very low-cost paper tests, although desirable,
has remained challenging, particularly in the context of instru-
mentation requirements. For example, sample pretreatment is
Table 1. Diagnostic accuracy of the paper-based microfluidic device, and of microscopy and RDT assays, compared with
the diagnosis of Plasmodium pan infection by real-time PCR
Field-based diagnostic tests
Real-time PCR
Sensitivity (%)* Sensitivity CI Coincidence rate (%)† Coincidence rate CIPositive Negative
CareStart Lateral Flow Test‡
Positive 46 0 82 77.0–87.0 83 78.1–87.9
Negative 10 3 82 77.0–87.0 83 78.1–87.9
Microscopy
Positive 48 0 85 80.4–89.6 86 81.5–90.5
Negative 8 3 85 80.4–89.6 86 81.5–90.5
Paper-based microfluidic device
Positive 55 1 98 96.2–99.8 96 93.4–98.6
Negative 1 2 98 96.2–99.8 96 93.4–98.6
*Defined as number of positives (positive by both the test and real-time PCR) over the total number of positives (by real-time PCR).
†Defined as the number of samples for which results agree between the test and real-time PCR over the total number of samples.
‡The RDT results were counted as being positive if either of the bands for P. falciparum or Plasmodium pan were positive.
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Fig. 4. Stability of rehydrated LAMP enzymes. (A) Real-time amplification
curves of a rehydrated enzyme stored at room temperature for up to 72 h.
The real-time amplification curves were normalized to 1 for ease of com-
parison; 0 h of storage (black square), 12 h (red circle), 24 h (blue triangle),
36 h (dark cyan triangle), 48 h (magenta triangle), 60 h (dark yellow triangle),
and 72 h (navy diamond). (B) Average threshold time (Tt) for different
storage conditions: 4 °C (black square), −20 °C (red triangle), and room
temperature (blue circle). Tt was used as a reaction kinetic and represents
the time corresponding to 50% of the maximum fluorescence intensity. Data
are the average of at least three replicates, and error bars represent the SD.
(C) Enzyme stability assayed using paper strips; 1, 0 h; 2, 12 h; 3, 24 h; 4, 36 h;
5, 48 h; 6, 60 h; and 7, 72 h of storage at room temperature. N is the negative
control.
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an essential first step for extracting and enriching the DNA of
parasites before diagnosis. The subsequent amplification and
detection steps also remain highly dependent on temperature
control, and low-cost, portable detection techniques are not
readily available (37).
Local environmental conditions also present challenges in
performing such multiplexed tests as “extreme point-of-need”
(38) diagnostics, and these cannot be underestimated. For exam-
ple, local variations and extremes in temperature and humidity
can affect reagent stabilities (39) as well as rates of evaporation
and speed of fluid movement during sample introduction into
microfluidic matrices. Similarly, care is needed in understanding
and controlling contamination between patients’ samples, partic-
ularly for NAAT-based technologies being delivered locally, where
standard GMP molecular biological processes cannot readily be
carried out. In this latter respect, the integration of both internal
positive and negative controls within the multiplex is essential to
ensure correct diagnosis.
The collection of dried blood spots on FTA cards can, in
principle, overcome many of these problems (particularly in ur-
ban environments or, for example, in refugee camps). However,
as a strategy, this remains impractical in the majority of remote
rural settings, where populations are highly dispersed, and where
the long transfer times between sample collection, analysis of
results, and the point of care makes the delivery of species-
specific treatment a significant burden, in terms of both its
economics and logistics.
Currently, significant advances are occurring within the field
of paper microfluidics and have recently been extensively
reviewed (21, 40, 41). For example, Connelly et al. (7) developed
a “paper machine” for molecular diagnosis of Escherichia coli
from human plasma using a magnetic device. To our knowledge,
the use of “origami” devices has previously been either for im-
munoassays [as ELISAs (42)] or only as a preanalytical self-
contained device for sample preparation, with no analytical
process integrated (43).
Here we combine sample processing from whole blood to-
gether with an easy-to-read visualization for the rapid readout of
diagnostic information. The simple manufacturing techniques,
which include hot wax printing and laser cutting, enabled devices
to be assembled within the laboratories at a cost of ∼$0.50 per
assay (triplex assay cost is <$2.00). The cost could be further
reduced in the future if manufactured at scale or in an industrial
setting. Device reliability during manufacture was extremely
good, and a robust quality control protocol ensured that there
were no failures in the field.
Conclusions
Our results demonstrate that paper-based microfluidic devices
can deliver precision diagnostics for malaria in low-resource,
underserved settings with a sensitivity that is higher than that of
the current malaria diagnostic tests used in the field (such as
microscopy and RDTs) and with performance that is similar to
that of a laboratory-based real-time PCR test. These diagnostic
devices could have a meaningful, positive impact on the provision
of mass screening and treatment in campaigns to eliminate in-
fectious disease (14). These campaigns have had limited success to
date in combating malaria transmission, which has been linked to
the inability of current field-based diagnostic tools to detect low-
level infections (44). Thus, the availability of easy-to-use, highly
sensitive NAATs, such as those provided by this device, could
potentially detect these missed cases and reduce the opportunity
for transmission. This not only would have a significant impact on
public health in areas where malaria is highly prevalent, but could
also inform current thinking within governments and non-
governmental organizations concerning improvements in the
effectiveness and cost-effectiveness of prophylactic approaches to
control diseases (where new precise diagnostic tools are required
to rapidly and accurately target where treatment is needed).
Materials and Methods
Materials and Reagents. Deionized water (DI H2O) with a resistivity of >18 MΩ·
cm was used to prepare all aqueous solutions transported from the United
Kingdom. Fresh bottled drinking water was purchased locally and used for
washing glassware and, for example, preparing Giemsa stains. Unless other-
wise specified, all other reagents were purchased from Sigma-Aldrich.
Multiplex LAMP System. The primer sets used for the LAMP assay were based
on previously published primer sequences for P. falciparum (45), and Plas-
modium genus (31). A LAMP assay that amplified a BCRA1 gene fragment
served as a positive control (46). The primers were all purchased from
Eurofins Genomics. The sequences are provided in SI Appendix, Table S1. The
20-μL LAMP reaction contained 0.5 μM inner primers (forward inner primer
and backward inner primer), 0.1 μM outer primers (F3 and B3), and 0.4 μM
loop primers, labeled with Biotin and FITC at their 5′ ends. The reaction mix
also contained 0.4 mM of each dNTPs (Sigma), 4.0 mM MgSO4, 50 mM Tris·
HCl (pH 8.1), 30 mM KCl, 30 mM (NH4)2SO4, 0.1% Triton X-100, 1 M Betaine,
and eight units of Gsp SSD 2.0 DNA polymerase (freeze-dried; OptiGene).
The multiplex LAMP reactions were performed at 65 °C for 45 min.
Paper-Based Microfluidic Device. The fabrication of the device was performed,
without specialized facilities or a clean room, simply by using a wax printer
(Xerox ColorQube 8570) (27, 47) and a hot plate. Each device contained a filter
paper-based fluidic device where the extracted DNA and the sample liquid
were constrained by printed hydrophobic wax (cat# 108R00935; Xerox).
The filter paper was first printed with the wax using the wax printer, then
heated at 120 °C for 1 min to 1.5 min on the hot plate to melt the printed
wax. The melted wax diffused through the filter paper, thus forming the
same hydrophobic pattern of channels on both sides. Subsequently, the glass
fiber spots (3 mm in diameter; Whatman) were manually positioned, such
that, when the paper was appropriately folded, the reagents and extracted
DNA could be transferred to the spots. After adding the LAMP master mix,
the plastic device was sealed using an acetate film, preventing liquid evap-
oration during amplification.
Lateral Flow Test. The plastic devices containing finger pumps and lateral flow
strips (Fig. 1) for field testing were manufactured by CNC machining at
Table 2. Diagnosis of P. falciparum infection using the paper-based microfluidic device and RDT, compared with real-time PCR
Field-based diagnostic tests
Real-time PCR
Sensitivity (%)* Sensitivity CI Coincidence rate, %† Coincidence rate CIPositive Negative
CareStart Lateral Flow Test‡
Positive 46 0 82 77.0–87.0 83 78.1−87.9
Negative 10 3 82 77.0–87.0 83 78.1−87.9
Paper-based microfluidic device P. falciparum
Positive 52 1 93 89.7–96.3 92 88.5–95.5
Negative 4 2 93 89.7–96.3 92 88.5–95.5
*Defined as number of positives (positive by both the test and real-time PCR) over the total number of positives (by real-time PCR).
†Defined as the number of samples for which results agree between the test and real-time PCR over the total number of samples.
‡The RDT results were counted as being positive if either of the bands for P. falciparum or Plasmodium pan were positive.
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Epigem Ltd. The dimensions are provided in SI Appendix, Fig. S5. A single-
sided adhesive acetate film (MicroAmp Optical Adhesive Film; Thermo Sci-
entific) sealed the plastic device plate with the LAMP reaction chambers,
which contained glass fiber spots that received DNA from the paper
fluidic device.
Quality Control. Air bubbles, generated during assembly of the paper strips
onto the plastic case, can lead to critical failure during processing. All devices
were inspected carefully for such air gaps and discarded if gaps were present.
This process was repeated before each assay. As stated, the devices’ designs
were fully characterized in a laboratory setting before field use, with no
subsequent additional quality check performed in the field.
As stated, we stored rehydrated LAMP mixtures under three different
conditions (−20 °C, 4 °C, and at room temperature, i.e., ∼22 °C) and checked
their stability both by PCR and by using the DNA detection strips, to show
that rehydrated enzymes can be stored for 3 d at room temperature (as cold
storage was not available). The use of both a positive control for the LAMP
reaction and a control line in the lateral flow assay enabled the validation of
results in the field.
Study Design. The aimof this studywas to demonstrate the performance of an
origami-lateral flow format, combining simple sample processing with easy
visualization of results. One additional objective was also to demonstrate the
potential role of multiplexed species-specific diagnosis from whole blood
finger pricks in rural, underserved communities. The diagnostic strips were
used to test blood samples collected from 67 school children from Bukagabo
Primary School, in the St. Kizito region, andMayuge and Apac District School,
Apac region. The sample size was calculated to provide enough samples for a
clear evaluation of sensitivity (with a power of >0.8 and P value of <0.05 for a
target sensitivity of >90%, yielding >30 positive samples), while, at the same
time, taking into account the practical limitation of carrying out the test
(limiting the numbers to 10/d to 20/d). Given the high prevalence (expected
above 70% based on epidemiological data, but, in practice, often >90% in
our study), we were not able to test for specificity (48).
This study was conducted with the Vector Control Division of the Ministry
of Health in Kampala, Uganda, on neglected tropical diseases, and was
approved by the Vector Control Division Research and Ethics Committee,
VCDREC/078, and Uganda National Council for Science and Technology (HS
2193). School children between the ages of 6 y and 14 y were recruited as a
cohort (balanced for sex) under the supervision of their class teachers. Each
child was assigned a unique identification number (ID), and their age, sex,
name, parents’ name (to ascertain consent), and school class were recorded.
Details without names were computerized and anonymized using the ID
numbers. No personal data were revealed to the investigators. Written in-
formed consent of the parents and the head teacher were also obtained.
The parents/guardians were informed of the activities by the head teacher
at community meetings, and their verbal and written assent for their
children’s participation was obtained. Where parents were unable to write,
their fingerprint was used as a signature (see SI Appendix. photos ESI-1 and
ESI-2). After testing, all patients were treated as malaria cases and given
antimalarial therapeutics, including cases that tested negative on site. This
follows guidance in the ethical approval obtained, given that all samples
were retested by PCR in the United Kingdom retrospectively, a method that
is more sensitive than the ones available onsite.
Ministry of Health Vector Control Division healthcare workers collected all
blood samples as finger-prick samples (<50 μL) either in 1.5-mL Eppendorf
tubes [for field reference methods, i.e., for Giemsa staining (see SI Appendix,
photo ESI-3) and microscopy, for CareStart Malaria RDTs (see SI Appendix,
photo ESI-4), or for storage on Whatman FTA (see SI Appendix, photo ESI-5)
classic cards and retrospective PCR analysis in the United Kingdom] or for
being placed on the paper device; see Microfluidic Testing for all details. As
stated, all samples were anonymized with an ID. Microfluidic testing, Giemsa
staining, and microscopy as well as diagnostic assessment with the RDT were
all carried out within the same school classrooms in parallel to testing on the
paper-based microfluidic device without sample storage. Testing was
double-blinded between on-site and reference tests. After testing at the
school, all used paper devices and small plastic consumables were in-
cinerated by burning on a bonfire, while glass slides and RDTs were stored in
a biohazard container for safe disposal at the Vector Control Division,
Kampala (SI Appendix, photo ESI-6).
We also provide data from a separate study of 20 negative samples, in SI
Appendix, Fig. S2, obtained in September 2018 from Adicon clinical labo-
ratories (Hangzhou, China) and validated on PCR. Five milliliters of whole
blood was obtained from patients using routine phlebotomy in a vacutainer,
coated with heparin. The blood was stored in a fridge until use (for less than
8 h). Five microliters of the sample was taken out of the tube and used on
the paper device, while 200 μL was processed for PCR (see Real-Time PCR).
This latter work was performed in a laboratory and in accordance with the
ethical standards of the institutional and national research committee and
with the 1964 Helsinki declaration and its later amendments or comparable
ethical standards. All procedures were carried out in accordance with Mea-
sures on Ethical Review over Biomedical Research Involving Human Subjects
(49). All of the samples were collected from patients after obtaining informed
consent, and the data from these patients were used in this study only.
Microfluidic Testing. In practice, three assays were typically run in parallel as a
triplex, which required ∼45 min to complete. All analysis was performed in
the children’s classrooms. Five microliters of human whole blood was
pretreated with 1 μL of proteinase K (20 mg/mL; Thermo) and 10 μL of
lysis buffer (4 M GUSCN, 25 mM sodium citrate, 0.2% SDS) in a 1.5-mL
Eppendorf tube and incubated at 60 °C for 5 min with 10 μL of cell lysis buffer,
and 1 μL of MagaZorb beads (diameter 4.5 μm) (Promega). Twenty microliters of
binding buffer (from MagaZorb kit; Promega) was mixed with the sample and
incubated at room temperature for 5 min. A 40-μL volume of the resulting
homogenous mixture was then added to the sample zone (Fig. 2B). The
beads remained at the surface of the sample zone while residues were
washed away to the waste pad through the filter paper.
The magnetic beads were washed with volume-independent washing
buffer (from MagaZorb kit; Promega) twice. The device was then folded to
bring the sample zone into contact with the distributing channel, before 40
μL of elution buffer (100 mM TE buffer, pH 8.0) was added to elute the DNA.
The eluted DNA was then guided to three different locations on the paper
within the wax-printed channel and transferred by capillary action to their
respective reaction chambers in the plastic device by making contact with a
paper pad inserted into the plastic chamber. The folded paper was then torn
away and incinerated for safe disposal. The independent chambers were
sealed with an acetate film to prevent liquid evaporation during the
isothermal amplification, following the addition of 16 μL of species-
specific LAMP reagents.
The LAMP isothermal reaction (n = 59) was performed on an electric-
powered hot plate, although, to demonstrate that the assay could be per-
formed without electric power, a small number (n = 8) were amplified in a
water bath, using a pan on a local cooking stove. The temperature of the
assays was maintained at around 63 °C by racking the chips in a metal block
with a high thermal heat capacity (sitting in water) and, when necessary,
controlling the distance between the pan and stove (see SI Appendix, photo
ESI-7). Temperature variations were ±3 °C around the target temperature. As
previously stated, and in all cases (n = 67), at the end of the incubation, the
running buffer chambers (1 in Fig. 1) were manually pressed to enable the
buffer to push the LAMP reaction mix onto the lateral flow device, as pre-
viously published (28), manufactured by Ustar Biotech Co., Ltd. Microfluidic
DNA test strips were imaged using an iPhone 6 camera on automatic setting,
as a digital record. No postprocessing was required for line intensity analysis
and diagnosis. SI Appendix, photo ESI-8 shows an example of such a strip.
Notwithstanding this, the intensities of the test and control lines were
analyzed and measured using ImageJ (50), and the intensity of the control
line (in the red channel) was divided by the intensity of the test line for each
strip to obtain the percentage intensity of the control line for each test (51).
Thick Blood Smears, Giemsa Staining, and Microscopy. Optical microscopy was
performed by trained technicians working for the Vector Control Division of
the Ministry of Health, Kampala. All healthcare workers were qualified and
all had >2 y of experience of field microscopy. SI Appendix, photo ESI-3
shows Giemsa staining and microscopy, with testing performed in the
school classrooms at the same time as microfluidic testing and RDT analysis.
For the thick film stain, a drop of blood from the finger prick was placed at
the center of a glass slide and spread as a smear. The slide was allowed to dry
under ambient conditions for 20 min and was then stained with 10% Giemsa
stain for a further 10 min.
Smears were examined under a compound microscope (made in Philip-
pines; Model CX21FS1; Olympus Corporation) using a 100× oil immersion
objective lens, with either electrical or natural light sources (depending
upon availability). Malaria parasites were counted against 200 white blood
cells (WBCs) and multiplied by factor 40 to give a parasitaemia per microliter
of blood (in 1 μL of blood) (52).
RDT Analysis. As stated, CareStart Malaria RDTs, provided by the Ministry of
Health, were used as a field reference technique, performed in the school
classrooms (see SI Appendix, photo ESI-4) at the same time as microfluidic testing
and thick film smears. We used the One step Malaria HRP-II (P. falciparum)
Reboud et al. PNAS Latest Articles | 7 of 9
EN
G
IN
EE
RI
N
G
BI
O
CH
EM
IS
TR
Y
and pLDH (P. pan) Antigen Rapid Test (SD Bioline Malaria Ag) P. falciparum/
Plasmodium pan test kit as a qualitative test method of detecting species-
specific Plasmodium of P. falciparum and Plasmodium pan (P. vivax, P.
malariae, or P. ovale) antigens in the individuals’ blood.
A finger prick of blood (5 μL) was transferred from the child’s finger to the
circular sample well. Four drops of CareStart assay diluent were then added
into the square assay diluent well, and the test device was allowed to stand
for 20 min (for capillary flows to enable the immunodiagnostic binding). A
positive P. falciparum was indicated by the presence of two colored bands
(“P. falciparum” test line and “C” control line) or three colored bands (“P.
falciparum” and “Plasmodium pan” test lines and “C” control line) within
the result window. Positive for other Plasmodium species (P. vivax,
P. malariae, or P. ovale) was indicated by the presence of two colored bands
(“pan” test line and “C” control line) within the result window regardless of
which band appears first. Mixed infections of P. falciparum and P. vivax (or P.
malariae and P. ovale) were indicated by the presence of three colored bands
(“P. falciparum” and “Plasmodium pan” test lines and “C” control line) within
the result window regardless of which band appears first. No malarial in-
fection was indicated by one line “C” in the result window [2015 One Step
Malaria HRP-II (P. falciparum) and pLDH (pan) Antigen Rapid Test “SD BIOLINE
Malaria Ag P.f/Pan test kit”; Standard Diagnostics, Inc.; https://www.alere.com/
en/home/products-services/brands/sd-bioline.html].
Dried Blood DNA Extraction. Finger-prick whole-blood samples were spotted
on FTA classic cards (Whatman) directly after bleeding, air-dried completely,
and, on return to the Vector Control Division, Kampala, shipped with a
desiccant at ambient temperature. Upon arrival in the United Kingdom, they
were stored at −20 °C until used. Three-millimeter sample discs from the
dried sample spot were removed using a disposable punch and placed in a
clean tube. Three hundred microliters of PBS was added to the tube, which
was then incubated at room temperature for 2 h, after which time 20 μL of
protein K was added, and the sample was incubated at 56 °C for 1 h. The
samples were further processed following the instructions from the Mag-
aZorb DNA Mini-Prep Kit (Promega) and eluted with 50 μL of elution buffer.
The extracted samples were coded randomly and dispensed in a 96-well
plate together with 10 negative (water) samples added at random.
Real-Time PCR. The 18S rRNA gene subunit-based Plasmodium sp. screening
real-time PCR and P. falciparum species-specific real-time PCR provided the
reference standard for assessing the diagnostic performance of the paper-
based microfluidic device reported in this program of work (6). The reaction
was performed as a double-blind study, in a final volume of 25 μL, which
contained 5 μL of DNA, 10 μL of Brilliant multiplex QPCR Master Mix (Agilent
Technologies), 200 nM forward primer, Plasmo1 (5′-GTTAAGGGAGTGAA-
GACGATCAGA-3′), and 200 nM reverse primer, Plasmo 2 (5′-AACCCAAA-
GACTTTGATTTCTCATAA-3′). The TaqMan probe, Plasprobe: 5′-FAM-
ACCGTCGTAA TCTTAACCATAAACTATGCCGACTAG-TAMRA-3′ and Falcprobe:
5′-FAM-AGCAATCTAA AAGTCACCTC GAAAGATGACT-TAMRA-3′ were used.
The real-time PCR was performed in an ABI 7500 fast real-time PCR
instrument (Applied Biosystems) with the following thermal profile: 95 °C
for 10 min, and 45 cycles of 95 °C for 15 s and 60 °C for 1 min. The sample
was considered positive by identifying the threshold cycle number (Ct) at
which normalized reporter dye emission raised above background noise. If
the fluorescent signal did not increase within 40 cycles (Ct 40), the sample
was considered negative.
The PCR was run on double-blinded samples by a different technician than
the one who had performed the DNA extraction. The results were recorded
by a third person and aligned with the blinded samples. Ten water samples
were added at random in the plate and were all negative. Two positive
samples showed a Ct value between 39 and 40. These samples were retested
(reextracted), and the final Ct was found to be 26 and 38. Individual results
are available in Dataset S1.
Statistics and Analysis (Including PCR). As stated, the intensity of the test and
control lines was analyzed and measured by using ImageJ (50). The intensity
of the control line (in the red channel) was divided by the intensity of the
test line for each strip to obtain the percentage intensity of the control line
for each test (51).
Confidence intervals for sensitivity data (Tables 1 and 2) were calculated
on the basis of the binomial distribution using the STATA 14.1 statistical
package (StataCorp LP).
Data and Materials Availability. All data are available open access in the
University of Glasgow repository (53).
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